SecBot SecBot

American Innovation and R&D Competitiveness Act of 2021

H.R. 1304 Rep. JOHN LARSON (D-CT-1) In committee
Bill text PDF
  1. Introduced Feb 24
  2. Committee Feb 24
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Feb 24, 2021Next: House vote
2072d ago Feb 24, 2021: Referred to the House Committee on Ways and Means.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 3 filings
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 1Technology & Software 1
Search all 2 companies, their asks and price moves Subscribe

Summary

American Innovation and R&D Competitiveness Act of 2021

Full summary1 paragraphs

This bill eliminates the five-year amortization requirement for research and experimental expenditures scheduled to begin in 2022, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred.

Library of Congress summary, Feb 24, 2021

Summary versions
  • Introduced in HouseFeb 24, 2021

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.